Economic, cognitive, and behavioural dimensions of medication non-adherence and their association with blood-pressure control among rural Bangladeshi adults with hypertension: a cross-sectional analysis

High blood pressure is a silent force that strains the heart and vessels, often without causing any immediate pain, yet it remains the leading cause of heart disease worldwide. In many places, especially in rural areas of developing nations, doctors can prescribe effective medicines to lower this pressure, but the treatment often fails to work as intended. The gap between having a prescription and actually keeping blood pressure under control usually comes down to adherence: whether a patient takes their medicine exactly as directed. For decades, researchers and doctors have treated this problem as a single issue, assuming that if a patient misses doses, it is simply because they are not following instructions. However, modern thinking suggests that missing a dose can happen for very different reasons. Sometimes a person forgets because of a busy schedule or memory lapses; other times, they might intentionally skip a dose because they feel better and believe they no longer need it; and frequently, they cannot afford to buy the medicine at all. Understanding which of these specific reasons is actually stopping the medicine from working is crucial, because the solution for a forgotten pill is different from the solution for an empty wallet.

A team of researchers in Bangladesh set out to untangle these different reasons by looking closely at adults living in the rural Kamalganj sub-district who were already diagnosed with high blood pressure. They gathered a large group of 446 people who were taking medication and asked them detailed questions about their experiences. Instead of just asking if they took their pills, the researchers used a specialized tool designed to separate the reasons for missing doses into three distinct categories: economic barriers, which involve the cost and availability of medicine; cognitive barriers, which involve memory and the unintentional act of forgetting; and behavioral barriers, which involve the deliberate choice to stop or change the dosage. By analyzing the answers in these separate groups, the researchers could see not only which problem was the most common but also which one was actually linked to high blood pressure readings.

The study revealed a surprising disconnect between what patients felt was their biggest struggle and what was actually keeping their blood pressure high. The most severe burden reported by the participants was economic. On average, the difficulty of affording medicine was the most pressing issue, with many people saying they could not buy their medication on time due to a lack of money. This problem was heavily concentrated among the poorest and least educated members of the community. However, despite being the most widespread and burdensome obstacle, the researchers found that these financial struggles did not independently predict whether a person's blood pressure was under control. In other words, while the poor were struggling the most to pay for their medicine, this specific struggle was not the primary driver of uncontrolled blood pressure in this group.

In contrast, the barrier that actually mattered for blood pressure control was the cognitive one, related to memory. The researchers found that people who reported more trouble remembering to take their pills, or taking them at the right time, were significantly more likely to have uncontrolled blood pressure. This was true even after accounting for age, education, and other health factors. The data showed that for every small improvement in a person's ability to remember their medication, their blood pressure readings dropped. This suggests that the act of forgetting, rather than the inability to pay, is the specific mechanism that breaks the chain of treatment effectiveness in this population. Interestingly, the deliberate choice to stop taking medicine was the least common problem and did not appear to influence blood pressure levels in this group.

The study also highlighted how these different problems affect different types of people. The financial burden fell heavily on those with lower incomes and less education, confirming that cost is a major equity issue. However, the memory-related problems followed a different pattern, becoming more common as people got older. Older adults were more likely to report forgetting their doses, while they were less likely to deliberately stop taking them. This creates a clear picture where the poorest patients face the biggest financial wall, but the oldest patients face the biggest memory wall. Since the memory wall is the one directly linked to high blood pressure, the researchers concluded that the most effective way to help older patients is to focus on memory aids, such as reminders or simpler pill schedules.

Ultimately, this research suggests that a one-size-fits-all approach to helping patients take their medicine is likely to fail. The most burdensome problem for the community was not the one causing the disease to worsen. Instead, the solution requires a targeted strategy that addresses the specific needs of different groups. For the socioeconomically disadvantaged, the priority should be financial protection to remove the heavy burden of cost. For older patients, the priority should be memory-focused strategies to prevent the unintentional lapses that directly lead to uncontrolled blood pressure. By separating these issues, doctors and policymakers can stop guessing and start applying the right fix to the right problem, ensuring that the medicine prescribed actually reaches the bloodstream where it is needed.